Inventor · disambiguated record
Zdenka Jerala-Strukelj
Also filed as: JERALA-STRUKELJ ZDENKA
4 granted patents·7 pending applications·69 citations·filing 1989–2012
76Inventor score
Files withLEK PHARMACEUTICALS4LEK TOVARNA FARMACEVTSKIH2ABRAMOVIC ZRINKA1ELANCO TIERGESUNDHEIT AG1KERC JANEZ1
Top patents by PatentIndex Score
11 records- 0190US8053444B2Sirolimus formulationLEK PHARMACEUTICALS·Filed 2008·Granted Nov 8, 2011·20 cites·7 claims
- 0273US5519012AInclusion complexes of optically active 1,4-dihydropyridines with methyl-β-cyclodextrinLEK TOVARNA FARMACEVTSKIH·Filed 1994·Granted May 21, 1996·27 cites·10 claims
- 0356US2011112160A1Tablet comprising eprosartan mesylateLEK PHARMACEUTICALS·Filed 2009·Application pending·0 cites
- 0456US2008299193A1Pharmaceutical composition comprising eszopliconeLEK PHARMACEUTICALS·Filed 2008·Application pending·0 cites
- 0554US5079237AInclusion complex of nicardipine or its hydrochloride with beta-cyclodextrin and a sustained release pharmaceutical preparation containing the sameLEK TOVARNA FARMACEVTSKIH·Filed 1989·Granted Jan 7, 1992·22 cites·9 claims
- 0654US2011135738A1Single dosage pharmaceutical formulation comprising eprosartan mesylateLEK PHARMACEUTICAL S D D·Filed 2009·Application pending·0 cites
- 0743US2008242725A1Pharmaceutical CompositionKERC JANEZ·Filed 2005·Application pending·0 cites
- 0840US10874618B2Compositions for treatment of heart failure in dogsELANCO TIERGESUNDHEIT AG·Filed 2012·Granted Dec 29, 2020·0 cites·2 claims
- 0940US2012027857A1Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxineABRAMOVIC ZRINKA·Filed 2009·Application pending·0 cites
- 1040US2008118564A1Pharmaceutical Composition Containing Candesartan Cilexetil as Lipophilic Crystalline SubstanceLEK PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 1132US2007298108A1Pharmaceutical FormulationSVETE PETER·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zdenka Jerala-Strukelj files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →